Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Engler currently holds 308,176 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Engler has been a net seller of HALO stock. They have purchased $168.1K and sold $1.5M worth of shares.
Robert Engler's most recent insider trade was on Aug 14, 2014, when they sold 75,000 shares at $2.05 per share.
Robert Engler serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 22 insider transactions totaling $1.7M over their tenure at the company.
Robert Engler holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert Engler has shown a selling trading pattern, with $168.1K in total purchases and $1.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Engler was on May 15, 2014, when they sold $957.9K worth of HALO shares. This transaction involved 126,700 shares at $7.56 per share.
Robert Engler currently owns 308,176 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Engler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Engler has 22 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for Robert Engler and 40,000+ other insiders.